2022
DOI: 10.1016/j.ajps.2022.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(26 citation statements)
references
References 117 publications
1
25
0
Order By: Relevance
“…PS could affect the depth of follicular penetration irrespective to the type of nanocarriers. It was stated that infiltration of follicular drugs developed by nanotechnology-based formulations could be enhanced by producing small-size particles to enlarge the surfaces with the stratum corneum [ 15 ]. Follicular targeting could be a remarkable selection to treat acne vulgaris, hirsutism, and androgenetic alopecia [ 16 ].…”
Section: Resultsmentioning
confidence: 99%
“…PS could affect the depth of follicular penetration irrespective to the type of nanocarriers. It was stated that infiltration of follicular drugs developed by nanotechnology-based formulations could be enhanced by producing small-size particles to enlarge the surfaces with the stratum corneum [ 15 ]. Follicular targeting could be a remarkable selection to treat acne vulgaris, hirsutism, and androgenetic alopecia [ 16 ].…”
Section: Resultsmentioning
confidence: 99%
“…To facilitate the observation of the insertion depth, PROTAC‐MNs were co‐loaded with Rhodamine B (RhB‐PROTAC‐MNs). In comparison to the untreated porcine skin, RhB‐PROTAC‐MNs can overcome the stratum corneum barrier and effectively transport the encapsulated cargoes to 200–300 µm deep in the skin, where most telogen HFs reside, [ 43 ] as confirmed by the red‐tapered microchannels after the insertion of RhB‐PROTAC‐MNs (Figure 2f). Most of the needles successfully penetrated into the skin, and completely disappeared after 5 min (Figure 2g).…”
Section: Resultsmentioning
confidence: 99%
“…The NLCs with a smaller particle size and occlusive properties can adhere themselves to the stratum corneum and form a thin film on the skin surface, achieving the desired effect of improving the penetration of the formulation as well as increasing hydration. [103][104][105] Angelo et al prepared nanostructured lipid carriers containing clobetasol propionate (NLC-CLO), which showed potential for epidermal targeting. [106] The NLC formulation exhibited great potential for CLO accumulation in HFs; the NLC-R6G provided fluorescence within the HFs at depths greater than 900 m (Figure 3e).…”
Section: Npsmentioning
confidence: 99%